GURUFOCUS.COM » STOCK LIST » Financial Services » Diversified Financial Services » ARYA Sciences Acquisition Corp III (NAS:ARYA) » Definitions » Loans Receivable

ARYA Sciences Acquisition III (ARYA Sciences Acquisition III) Loans Receivable : $0.00 Mil (As of Mar. 2021)


View and export this data going back to 2020. Start your Free Trial

What is ARYA Sciences Acquisition III Loans Receivable?

ARYA Sciences Acquisition III's Loans Receivable for the quarter that ended in Mar. 2021 was $0.00 Mil.


ARYA Sciences Acquisition III Loans Receivable Historical Data

The historical data trend for ARYA Sciences Acquisition III's Loans Receivable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

ARYA Sciences Acquisition III Loans Receivable Chart

ARYA Sciences Acquisition III Annual Data
Trend Dec20
Loans Receivable
-

ARYA Sciences Acquisition III Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21
Loans Receivable - - - - -

ARYA Sciences Acquisition III Loans Receivable Calculation

Loans Receivable are the funds that a company has lent but have not yet been repaid.


ARYA Sciences Acquisition III Loans Receivable Related Terms

Thank you for viewing the detailed overview of ARYA Sciences Acquisition III's Loans Receivable provided by GuruFocus.com. Please click on the following links to see related term pages.


ARYA Sciences Acquisition III (ARYA Sciences Acquisition III) Business Description

Comparable Companies
Traded in Other Exchanges
N/A
Address
51 Astor Place, 10th Floor, New York, NY, USA, 10003
Website
ARYA Sciences Acquisition Corp III is a blank check company.
Executives
Adam Leo Stone director, 10 percent owner, officer: Chief Executive Officer C/O SOLID BIOSCIENCES, LLC, 141 PORTLAND STREET, FIFTH FLOOR, CAMBRIDGE MA 02139
Michael Seth Altman director, 10 percent owner, officer: Chief Financial Officer C/O PERCEPTIVE ADVISORS, 51 ASTOR PLACE, 10TH FLOOR, NEW YORK NY 10003
Arya Sciences Holdings Iii 10 percent owner 51 ASTOR PLACE, 10TH FLOOR, NEW YORK NY 10003
Saqib Islam director ALEXION PHARMACEUTICALS, 352 KNOTTER DRIVE, CHESHIRE CT 06410
Joseph Edelman director C/O PERCEPTIVE ADVISORS LLC, 51 ASTOR PLACE, 10TH FLOOR, NEW YORK NY 10003
Todd Wider director 4848 LEMMON AVENUE, SUITE 517, DALLAS TX 75219
Bradley L Campbell director C/O AMICUS THERAPEUTICS, INC., 1 CEDAR BROOK DRIVE, CRANBURY NJ 08512
Konstantin Poukalov officer: Chief Business Officer C/O KADMON HOLDINGS, LLC, 450 E 29TH STREET, NEW YORK NY 10016